Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16947041rdf:typepubmed:Citationlld:pubmed
pubmed-article:16947041lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1527249lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1514474lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:16947041lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:16947041pubmed:issue5lld:pubmed
pubmed-article:16947041pubmed:dateCreated2007-3-20lld:pubmed
pubmed-article:16947041pubmed:abstractTextThe HER-2/neu protein is intimately involved with normal cell proliferation and tissue growth, as it is extensively homologous and is related to the epidermal growth factor receptor. This phenomenon has been most intensively studied in the context of breast carcinoma, in which its amplification and overexpression correlate with the overall course of disease and poor prognoses, and also constitute a predictive factor of poor response to chemotherapy and endocrine therapy. In this study, we investigated the relationships between the expression of HER-2/neu and the clinicopathological characteristics of colorectal cancer, including survival. This study was performed with a view toward the future introduction of Herceptin therapy for colorectal cancer patients.lld:pubmed
pubmed-article:16947041pubmed:languageenglld:pubmed
pubmed-article:16947041pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16947041pubmed:citationSubsetIMlld:pubmed
pubmed-article:16947041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16947041pubmed:statusMEDLINElld:pubmed
pubmed-article:16947041pubmed:monthMaylld:pubmed
pubmed-article:16947041pubmed:issn0179-1958lld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:SepulvedaAnto...lld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:KimHong JooHJlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:ParkDong IlDIlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:HanWon KonWKlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:RyuSeung HoSHlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:ChoYong...lld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:SohnChong...lld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:JeonWoo KyuWKlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:KimByung IkBIlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:OhSuk JoongSJlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:KangMun SuMSlld:pubmed
pubmed-article:16947041pubmed:authorpubmed-author:KimHungdaiHlld:pubmed
pubmed-article:16947041pubmed:issnTypePrintlld:pubmed
pubmed-article:16947041pubmed:volume22lld:pubmed
pubmed-article:16947041pubmed:ownerNLMlld:pubmed
pubmed-article:16947041pubmed:authorsCompleteYlld:pubmed
pubmed-article:16947041pubmed:pagination491-7lld:pubmed
pubmed-article:16947041pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:meshHeadingpubmed-meshheading:16947041...lld:pubmed
pubmed-article:16947041pubmed:year2007lld:pubmed
pubmed-article:16947041pubmed:articleTitleHER-2/neu overexpression is an independent prognostic factor in colorectal cancer.lld:pubmed
pubmed-article:16947041pubmed:affiliationDepartment of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.lld:pubmed
pubmed-article:16947041pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16947041pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2064entrezgene:pubmedpubmed-article:16947041lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16947041lld:entrezgene
lhgdn:association:54543lhgdn:found_inpubmed-article:16947041lld:lhgdn
lhgdn:association:54600lhgdn:found_inpubmed-article:16947041lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16947041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16947041lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16947041lld:pubmed